Despite the popularity of semaglutide drugs like Ozempic and Wegovy for weight loss, surveys suggest that most people still ...

In 'Diet, Drugs, and Dopamine,' former FDA Commissioner David A. Kessler offers a comprehensive guide to weight loss.

New research presented May 17 at the American Psychiatric Association's Annual Meeting shows that GLP-1 receptor agonists may ...

Cognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

“Fructo-oligosaccharides (FOS) are prebiotic fibers that have a significant impact on the secretion and function of the natural hormone GLP-1, which plays a crucial role in glucose regulation, ...

For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is not ...

South Carolina Medicaid approved GLP-1s to treat obesity, placing it among the few state programs covering the drugs. But ...

Discover how popular GLP-1 weight loss medications like Ozempic may trigger eating disorder relapse in vulnerable users and ...

Omada Health is launching new AI tools for nutrition care after filing its S-1 to go public.

Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...